Enovis Gross Profit 2011-2025 | ENOV
Enovis gross profit from 2011 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
|
Enovis Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2024 | $1,181 |
| 2023 | $991 |
| 2022 | $869 |
| 2021 | $778 |
| 2020 | $604 |
| 2019 | $1,401 |
| 2018 | $729 |
| 2017 | $672 |
| 2016 | $992 |
| 2015 | $1,072 |
| 2014 | $1,479 |
| 2013 | $1,306 |
| 2012 | $1,152 |
| 2011 | $240 |
| 2010 | $191 |
|
Enovis Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2025-06-30 | $335 |
| 2025-03-31 | $332 |
| 2024-12-31 | $308 |
| 2024-09-30 | $286 |
| 2024-06-30 | $289 |
| 2024-03-31 | $298 |
| 2023-12-31 | $264 |
| 2023-09-30 | $243 |
| 2023-06-30 | $248 |
| 2023-03-31 | $235 |
| 2022-12-31 | $232 |
| 2022-09-30 | $216 |
| 2022-06-30 | $216 |
| 2022-03-31 | $206 |
| 2021-12-31 | $8 |
| 2021-09-30 | $198 |
| 2021-06-30 | $201 |
| 2021-03-31 | $371 |
| 2020-12-31 | $-330 |
| 2020-09-30 | $344 |
| 2020-06-30 | $241 |
| 2020-03-31 | $348 |
| 2019-12-31 | $396 |
| 2019-09-30 | $368 |
| 2019-06-30 | $376 |
| 2019-03-31 | $261 |
| 2018-12-31 | $96 |
| 2018-09-30 | $171 |
| 2018-06-30 | $192 |
| 2018-03-31 | $271 |
| 2017-12-31 | $-90 |
| 2017-09-30 | $264 |
| 2017-06-30 | $258 |
| 2017-03-31 | $240 |
| 2016-12-31 | $172 |
| 2016-09-30 | $238 |
| 2016-06-30 | $301 |
| 2016-03-31 | $281 |
| 2015-12-31 | $153 |
| 2015-09-30 | $296 |
| 2015-06-30 | $328 |
| 2015-03-31 | $294 |
| 2014-12-31 | $392 |
| 2014-09-30 | $373 |
| 2014-06-30 | $388 |
| 2014-03-31 | $326 |
| 2013-12-31 | $357 |
| 2013-09-30 | $320 |
| 2013-06-30 | $338 |
| 2013-03-31 | $291 |
| 2012-12-31 | $308 |
| 2012-09-30 | $288 |
| 2012-06-30 | $315 |
| 2012-03-31 | $242 |
| 2011-12-31 | $62 |
| 2011-09-30 | $61 |
| 2011-06-30 | $65 |
| 2011-03-31 | $53 |
| 2010-12-31 | $60 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.800B | $2.108B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $48.395B | 59.05 |
| Tempus AI (TEM) | United States | $14.291B | 0.00 |
| Doximity (DOCS) | United States | $11.985B | 53.33 |
| Hims & Hers Health (HIMS) | United States | $9.884B | 76.72 |
| IRhythm Technologies (IRTC) | United States | $5.815B | 0.00 |
| Hinge Health (HNGE) | United States | $3.560B | 0.00 |
| Privia Health (PRVA) | United States | $3.071B | 227.46 |
| Heartflow (HTFL) | United States | $2.895B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.406B | 39.82 |
| 10x Genomics (TXG) | United States | $1.679B | 0.00 |
| Omnicell (OMCL) | United States | $1.642B | 32.79 |
| Clover Health Investments (CLOV) | United States | $1.520B | 0.00 |
| Schrodinger (SDGR) | United States | $1.455B | 0.00 |
| Azenta (AZTA) | United States | $1.400B | 61.08 |
| Phreesia (PHR) | United States | $1.358B | 0.00 |
| Claritev (CTEV) | United States | $1.071B | 0.00 |
| Evolent Health (EVH) | United States | $0.746B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.697B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.632B | 0.00 |
| Talkspace (TALK) | United States | $0.576B | 114.67 |
| Veradigm (MDRX) | United States | $0.520B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.505B | 0.00 |
| Standard BioTools (LAB) | United States | $0.438B | 0.00 |
| Carlsmed (CARL) | United States | $0.322B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.305B | 0.00 |
| TruBridge (TBRG) | United States | $0.290B | 50.76 |
| CapsoVision (CV) | United States | $0.226B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.223B | 0.00 |
| Outset Medical (OM) | United States | $0.223B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.215B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.191B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.186B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.170B | 0.00 |
| CareCloud (CCLD) | United States | $0.125B | 5.67 |
| EUDA Health Holdings (EUDA) | Singapore | $0.119B | 0.00 |
| American Well (AMWL) | United States | $0.074B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.073B | 0.00 |
| Pulmonx (LUNG) | United States | $0.069B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| 111 (YI) | China | $0.038B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.036B | 0.00 |
| Precipio (PRPO) | United States | $0.033B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.027B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.027B | 0.00 |
| Zhongchao (ZCMD) | China | $0.018B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |